Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

119-65-3

Isoquinoline

119-65-3
75695-93-1

Isradipine

75695-93-1
87-89-8

Inositol

87-89-8
35175-14-5

Ipronidazole Hydroxy

35175-14-5
NA

Impuretes A,B,D et C de repaglinide

NA
87-33-2

Isosorbide dinitrate

87-33-2
152459-95-5

Imatinib

152459-95-5
66985-17-9

Ipratropium Bromide Monohydrate

66985-17-9
55-22-1

Isonicotinic Acid

55-22-1
338-95-4

Isoflupredone

338-95-4
4803-57-0

5,6-Dimethoxy-2-(4-pyridylmethyl)-1-indanone

4803-57-0
480-79-5

Integerrimine

480-79-5
38861-78-8

4'-Isobutylacetophenone

38861-78-8
51146-56-6

(S)-(+)-Ibuprofen

51146-56-6
514-53-4

Isochlortetracycline

514-53-4
15935-54-3

Ibuprofen Carboxylic Acid(Mixof Diastereomers)

15935-54-3
122892-31-3

Itopride Hydrochloride

122892-31-3
50-96-4

Isoetharine HCl

50-96-4
64519-82-0

Isomalt

64519-82-0
487-60-5

Indican

487-60-5